1. Chronic Administration of Valproic Acid Inhibits Prostate Cancer Cell Growth In vitro and In vivo
   Qinghua Xia et al, 2006, Cancer Research CrossRef
2. Valproic Acid Alters Chromatin Structure by Regulation of Chromatin Modulation Proteins
   Douglas C. Marchion et al, 2005, Cancer Research CrossRef
3. Cancer Risk in Long-term Users of Valproate: A Population-Based Case-Control Study
   Jesper Hallas et al, 2009, Cancer Epidemiology, Biomarkers & Prevention CrossRef
4. Thrombospondin-1 Peptide ABT-510 Combined with Valproic Acid Is an Effective Antiangiogenesis Strategy in Neuroblastoma
   Qiwei Yang et al, 2007, Cancer Research CrossRef
5. Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC
   Xiao-Nan Li et al, 2005, Molecular Cancer Therapeutics CrossRef
6. In vivo synergy between topoisomerase II and histone deacetylase inhibitors: predictive correlates
   Douglas C. Marchion et al, 2005, Molecular Cancer Therapeutics CrossRef
7. Targeting Histone Deacetylases with Natural and Synthetic Agents: An Emerging Anticancer Strategy
   Amit Singh et al, 2018, Nutrients CrossRef
8. Histone Deacetylase Inhibitors as Anticancer Drugs
   Tomas Eckschlager et al, 2017, International Journal of Molecular Sciences CrossRef